PFKM and cancer: Awaiting the development of non-toxic inhibitors of PFK1 and PFKFB3, we will emphasize how in cultured cancer cells of diverse origins, the targeting of PFK1 has been achieved by the administration of high dosages of citrate, a physiologic inhibitor of PFK1.